Tocit XR 11 mg Tablet (Extended Release)

75.00৳  Original price was: 75.00৳ .67.87৳ Current price is: 67.87৳ .
In Stock

Dosage : Tablet (Extended Release)
Strength : 11 mg
Generic : Tofacitinib
Pack Size : 1 Pack = 14’s
Manufacturer : Drug International Ltd.

In Stock
  • 100% āφāϏāϞ āĻ“ āĻŽāĻžāύāϏāĻŽā§āĻĒāĻ¨ā§āύ āĻ“āώ⧁āϧ – āφāĻĒāύāĻžāϰ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ⧇āϰ āϜāĻ¨ā§āϝ āφāĻŽāĻžāĻĻ⧇āϰ āĻĒā§āϰāϤāĻŋāĻļā§āϰ⧁āϤāĻŋāĨ¤
  • ⧝⧝⧝+ āϟāĻžāĻ•āĻžāϰ āϕ⧇āύāĻžāĻ•āĻžāϟāĻž āĻ•āϰ⧁āύ āĻāĻŦāĻ‚ āĻĢā§āϰāĻŋ āĻšā§‹āĻŽ āĻĄā§‡āϞāĻŋāĻ­āĻžāϰāĻŋ āωāĻĒāĻ­ā§‹āĻ— āĻ•āϰ⧁āύ!
  • āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ āĻāϞāĻžāĻ•āĻžāϝāĻŧ āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻĄā§‡āϞāĻŋāĻ­āĻžāϰāĻŋ āϚāĻžāĻ°ā§āϜ āĻŽāĻžāĻ¤ā§āϰ ⧍ā§Ģ āϟāĻžāĻ•āĻžāĨ¤
  • āĻ…āĻ°ā§āĻĄāĻžāϰ⧇āϰ āĻĒāϰ āĻĄā§‡āϞāĻŋāĻ­āĻžāϰāĻŋ āϏāĻŽāϝāĻŧ ā§§-ā§Ēā§Ž āϘāĻŖā§āϟāĻžāĨ¤
  • āĻ”āώāϧ āωāĻĒāϞāĻ­ā§āϝ āύāĻž āĻĨāĻžāĻ•āϞ⧇ āĻĄā§‡āϞāĻŋāĻ­āĻžāϰāĻŋ āĻŦāĻŋāϞāĻŽā§āĻŦāĻŋāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇ āĻŦāĻž āĻ…āĻ°ā§āĻĄāĻžāϰ āĻŦāĻžāϤāĻŋāϞ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āĻ•āĻžāϰāĻŋāĻ—āϰāĻŋ āĻ¤ā§āϰ⧁āϟāĻŋāϰ āĻ•āĻžāϰāϪ⧇ āĻĒāĻŖā§āϝ⧇āϰ āĻŽā§‚āĻ˛ā§āϝ āĻ…āϏāĻ™ā§āĻ—āϤāĻŋāĻĒā§‚āĻ°ā§āĻŖ āĻšāϞ⧇, āĻ•āĻ°ā§āϤ⧃āĻĒāĻ•ā§āώ āĻ…āĻ°ā§āĻĄāĻžāϰ āĻŦāĻžāϤāĻŋāϞ⧇āϰ āĻ…āϧāĻŋāĻ•āĻžāϰ āϏāĻ‚āϰāĻ•ā§āώāĻŖ āĻ•āϰ⧇āĨ¤
SKU: 1738192

Description

Rheumatoid Arthritis: Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily.?Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.

Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily.? Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.

Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.

Reviews

There are no reviews yet.

Be the first to review “Tocit XR 11 mg Tablet (Extended Release)”

Your email address will not be published. Required fields are marked *